• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用低剂量血浆源性疫苗经皮内途径对乙型肝炎病毒(HBV)进行主动免疫。

Active immunization against hepatitis B virus (HBV) with low-doses of plasma-derived vaccine by intradermal route.

作者信息

Carrilho F J, Queiroz M L, da Silva L C, da Fonseca L E, Granato C, Oba I, Obara L

出版信息

Rev Inst Med Trop Sao Paulo. 1989 Mar-Apr;31(2):91-4. doi: 10.1590/s0036-46651989000200005.

DOI:10.1590/s0036-46651989000200005
PMID:2602806
Abstract

Schedule for vaccination against HBV infection has usually been based on three separate injections of 20 mcg of the vaccine by intramuscular route. One of the main shortcomings to its use in large scale programs has been its high cost. Ninety out of 300 health workers were submitted to three injections of 2 mcg of plasma-derived vaccine (PDV) by intradermal (ID) route on days 0, 30, and 180. Anti-HBs was detected in 74 (82.2%) after the second dose and in 80 (88.9%) after the third dose, a non-significant difference. However, levels above 10 times the cut-off were observed in 29 (32.2%) and 77 (85.5%), respectively (p less than 0.001). The results showed that a low-dose schedule is effective when used in health workers and should be tried with other risk groups.

摘要

乙型肝炎病毒(HBV)感染的疫苗接种计划通常是通过肌肉注射途径分三次单独注射20微克疫苗。其在大规模项目中使用的主要缺点之一是成本高昂。300名医护人员中有90人在第0、30和180天通过皮内(ID)途径接受了三次2微克血浆源性疫苗(PDV)注射。第二次注射后,74人(82.2%)检测到抗-HBs,第三次注射后80人(88.9%)检测到抗-HBs,差异无统计学意义。然而,分别有29人(32.2%)和77人(85.5%)观察到高于临界值10倍的水平(p小于0.001)。结果表明,低剂量接种计划在医护人员中使用时是有效的,应该在其他风险群体中进行尝试。

相似文献

1
Active immunization against hepatitis B virus (HBV) with low-doses of plasma-derived vaccine by intradermal route.采用低剂量血浆源性疫苗经皮内途径对乙型肝炎病毒(HBV)进行主动免疫。
Rev Inst Med Trop Sao Paulo. 1989 Mar-Apr;31(2):91-4. doi: 10.1590/s0036-46651989000200005.
2
Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.肌内注射与低剂量皮内注射乙型肝炎疫苗。通过对乙型肝炎表面抗原的体液和细胞免疫反应进行评估。
Med J Aust. 1987 Mar 2;146(5):242-5.
3
Intradermal vaccination against hepatitis B in Immanuel Hospital personnel--a preliminary report.伊曼纽尔医院工作人员的乙肝皮内接种——初步报告
Ann Acad Med Singap. 1986 Apr;15(2):153-7.
4
Active immunization against hepatitis B virus (HBV) with low-doses of plasma-derived vaccine by intradermal route. Anti HBs response after 3 years of follow-up.
Rev Inst Med Trop Sao Paulo. 1991 Mar-Apr;33(2):167. doi: 10.1590/s0036-46651991000200013.
5
Effectiveness of intradermal hepatitis B immunization of hospital staff.医院工作人员皮内注射乙肝疫苗的有效性。
Int J STD AIDS. 1990 Jan;1(1):32-4. doi: 10.1177/095646249000100108.
6
Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response.乙型肝炎疫苗的皮内、皮下或肌内注射:副作用及抗体反应
Scand J Infect Dis. 1987;19(6):617-21. doi: 10.3109/00365548709117195.
7
Hepatitis B vaccine in developing countries: problems and prospects.发展中国家的乙肝疫苗:问题与前景
IARC Sci Publ. 1984(63):297-305.
8
Efficacy of low dose intradermal hepatitis B vaccine: results of a randomized trial among health care workers.低剂量皮内注射乙肝疫苗的疗效:医护人员随机试验结果
Trop Gastroenterol. 2002 Jul-Sep;23(3):120-1.
9
Vaccines for preventing hepatitis B in health-care workers.医护人员预防乙型肝炎的疫苗。
Cochrane Database Syst Rev. 2005 Oct 19(4):CD000100. doi: 10.1002/14651858.CD000100.pub3.
10
Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation.非反应性慢性透析患者皮内与肌内乙型肝炎再接种:一项具有成本效益评估的前瞻性随机研究
Nephrol Dial Transplant. 1997 Jun;12(6):1204-11. doi: 10.1093/ndt/12.6.1204.

引用本文的文献

1
Hepatitis B and hepatitis delta virus infection in South America.南美洲的乙型肝炎和丁型肝炎病毒感染
Gut. 1996;38 Suppl 2(Suppl 2):S48-55. doi: 10.1136/gut.38.suppl_2.s48.